312 related articles for article (PubMed ID: 3134658)
1. Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines.
Diaz MO; Ziemin S; Le Beau MM; Pitha P; Smith SD; Chilcote RR; Rowley JD
Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5259-63. PubMed ID: 3134658
[TBL] [Abstract][Full Text] [Related]
2. Deletions of interferon genes in acute lymphoblastic leukemia.
Diaz MO; Rubin CM; Harden A; Ziemin S; Larson RA; Le Beau MM; Rowley JD
N Engl J Med; 1990 Jan; 322(2):77-82. PubMed ID: 2294436
[TBL] [Abstract][Full Text] [Related]
3. Refined mapping of genomic rearrangements involving the short arm of chromosome 9 in acute lymphoblastic leukemias and other hematologic malignancies.
Dreyling MH; Bohlander SK; Le Beau MM; Olopade OI
Blood; 1995 Sep; 86(5):1931-8. PubMed ID: 7544647
[TBL] [Abstract][Full Text] [Related]
4. Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers.
Olopade OI; Buchhagen DL; Malik K; Sherman J; Nobori T; Bader S; Nau MM; Gazdar AF; Minna JD; Diaz MO
Cancer Res; 1993 May; 53(10 Suppl):2410-5. PubMed ID: 7683574
[TBL] [Abstract][Full Text] [Related]
5. Genomic cloning of methylthioadenosine phosphorylase: a purine metabolic enzyme deficient in multiple different cancers.
Nobori T; Takabayashi K; Tran P; Orvis L; Batova A; Yu AL; Carson DA
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):6203-8. PubMed ID: 8650244
[TBL] [Abstract][Full Text] [Related]
6. Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer.
Stadler WM; Sherman J; Bohlander SK; Roulston D; Dreyling M; Rukstalis D; Olopade OI
Cancer Res; 1994 Apr; 54(8):2060-3. PubMed ID: 7513608
[TBL] [Abstract][Full Text] [Related]
7. Distinct deletions of chromosome 9p associated with melanoma versus glioma, lung cancer, and leukemia.
Coleman A; Fountain JW; Nobori T; Olopade OI; Robertson G; Housman DE; Lugo TG
Cancer Res; 1994 Jan; 54(2):344-8. PubMed ID: 8275465
[TBL] [Abstract][Full Text] [Related]
8. P16INK4A gene homozygous deletions in human acute leukaemias with alterations of chromosome 9.
Faienza MF; della Ragione F; Basso G; Coppola B; Miraglia del Giudice E; Schettini F; Iolascon A
Br J Haematol; 1996 Jun; 93(3):632-6. PubMed ID: 8652384
[TBL] [Abstract][Full Text] [Related]
9. Deletion of alpha-, beta-, and omega-interferon genes in malignant cells from children with acute lymphocytic leukemia.
Einhorn S; Grandér D; Björk O; Bröndum-Nielsen K; Söderhäll S
Cancer Res; 1990 Dec; 50(24):7781-5. PubMed ID: 1701354
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas.
Olopade OI; Jenkins RB; Ransom DT; Malik K; Pomykala H; Nobori T; Cowan JM; Rowley JD; Diaz MO
Cancer Res; 1992 May; 52(9):2523-9. PubMed ID: 1568221
[TBL] [Abstract][Full Text] [Related]
11. Lymphoblastic leukemia with lymphomatous features associated with abnormalities of the short arm of chromosome 9.
Chilcote RR; Brown E; Rowley JD
N Engl J Med; 1985 Aug; 313(5):286-91. PubMed ID: 3925340
[TBL] [Abstract][Full Text] [Related]
12. 5'-Deoxy-5'-methylthioadenosine phosphorylase and p16INK4 deficiency in multiple tumor cell lines.
Della Ragione F; Russo G; Oliva A; Mastropietro S; Mancini A; Borrelli A; Casero RA; Iolascon A; Zappia V
Oncogene; 1995 Mar; 10(5):827-33. PubMed ID: 7898924
[TBL] [Abstract][Full Text] [Related]
13. CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia.
Bertin R; Acquaviva C; Mirebeau D; Guidal-Giroux C; Vilmer E; Cavé H
Genes Chromosomes Cancer; 2003 May; 37(1):44-57. PubMed ID: 12661005
[TBL] [Abstract][Full Text] [Related]
14. Mapping of the shortest region of overlap of deletions of the short arm of chromosome 9 associated with human neoplasia.
Olopade OI; Bohlander SK; Pomykala H; Maltepe E; Van Melle E; Le Beau MM; Diaz MO
Genomics; 1992 Oct; 14(2):437-43. PubMed ID: 1385305
[TBL] [Abstract][Full Text] [Related]
15. Homozygous deletions of methylthioadenosine phosphorylase (MTAP) are more frequent than p16INK4A (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC).
Schmid M; Malicki D; Nobori T; Rosenbach MD; Campbell K; Carson DA; Carrera CJ
Oncogene; 1998 Nov; 17(20):2669-75. PubMed ID: 9840931
[TBL] [Abstract][Full Text] [Related]
16. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR
Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033
[TBL] [Abstract][Full Text] [Related]
17. Gene deletion chemoselectivity: codeletion of the genes for p16(INK4), methylthioadenosine phosphorylase, and the alpha- and beta-interferons in human pancreatic cell carcinoma lines and its implications for chemotherapy.
Chen ZH; Zhang H; Savarese TM
Cancer Res; 1996 Mar; 56(5):1083-90. PubMed ID: 8640765
[TBL] [Abstract][Full Text] [Related]
18. Analysis of tumor suppressor gene on human chromosome 9 in mouse x human somatic cell hybrids.
Porterfield BW; Olopade OI; Rowley JD; Diaz MO
Somat Cell Mol Genet; 1994 Sep; 20(5):391-400. PubMed ID: 7825061
[TBL] [Abstract][Full Text] [Related]
19. Homozygous deletions within 9p21-p22 identify a small critical region of chromosomal loss in human malignant mesotheliomas.
Cheng JQ; Jhanwar SC; Lu YY; Testa JR
Cancer Res; 1993 Oct; 53(20):4761-3. PubMed ID: 8402655
[TBL] [Abstract][Full Text] [Related]
20. Interferon system defects in malignant T-cells.
Heyman M; Grandér D; Bröndum-Nielsen K; Cederblad B; Liu Y; Xu B; Einhorn S
Leukemia; 1994 Mar; 8(3):425-34. PubMed ID: 8127147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
